During the annual IBD Education Day, a panel of health specialists explored the aspects of living with IBD, and patients shared their experience.

Prenatal gene editing shows proof-of-concept in treating congenital disease before birth.

CHOP experts describe their experience with corneal neurotization, a technique involving the transfer of healthy donor nerve into a tissue to re-establish motor or sensory innervation in children with neurotrophic cornea.

CHOP researchers used automated tools to identify sepsis in NICU babies hours before clinical recognition of the condition.

This prestigious designation recognizes organizations that provide the highest-quality care.

New results in cell and animal studies suggest that a drug already used for a rare kidney disease could benefit patients with mitochondrial disorders.

The Fore Hadley Foundation presented CHOP with a $55,000 grant to support congenital diaphragmatic hernia (CDH) research. The grant will support the research of Drs. Ian Krantz and William Peranteau.

CHOP participated in an international, multi-site study to determine if a skin patch could help children with peanut allergies.

Specialized lung cells appear in the developing fetus much earlier than previously thought. Understanding early signaling pathways may lead to future treatments for lung damage.

Modern Healthcare recognized Madeline Bell, President and CEO of CHOP, for her innovative leadership and commitment to nurturing diversity.